Blogs

Note to FDA and Narrow-Minded Pharma: Is it Time to Rethink “Quality by Design?”

Avandia: Lies, Damned Lies…and Statistics

Putman Will Soon Launch a Process Analytical Technologies /Quality by Design Wiki

De-hyping RFID: Advice from W.C. Fields

Pharma and FDA: BIOCOM Survey Finds Communication, Agency Turnover are Key Problems

Drug Manufacturing and the Innovation Deficit: Amgen’s Perlmutter and FDA’s Winkle Discuss Issues

Pharma, QbD and Bikash Chatterjee’s “Argument for Change” in FDA and Industry

Big Pharma and Lessons From Detroit’s Big Three: Focus on API Manufacturing, Or Lose Your Edge to Offshore Generics

Ajaz and Me